Check out our most popular compounded medications! Get Started
Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This formulation is beneficial for reducing dosing frequency and improving patient compliance, particularly for medications requiring a controlled and prolonged release profile. These capsules are used to treat conditions such as Epilepsy, Anxiety, Insomnia, Hypertension, and Migraine.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules are a specially compounded formulation designed to provide sustained relief from a variety of conditions such as seizures, anxiety, insomnia, and muscle spasms. This unique formulation combines the therapeutic benefits of belladonna extract and phenobarbital, working synergistically to reduce the severity of symptoms associated with these conditions.
These capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. Monitoring for potential side effects such as drowsiness, dizziness, or confusion is also important to ensure safe use.
If you have any questions or concerns about the Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to assist you in understanding your medication and ensuring you receive the maximum benefit from it.
Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, including anticholinergics, antacids, and anticonvulsants. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Awareness of potential drug-drug interactions, as well as potential drug-disease interactions, is essential.
Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules may be used to treat conditions such as seizures, anxiety, and insomnia. However, this formulation may cause drowsiness and should be used with caution in patients with impaired motor coordination or judgment. Monitoring for signs of sedation is necessary, and patients should refrain from driving or operating machinery until they are certain they can do so safely.
Interaction with alcohol may also occur when taking these capsules, increasing the risk of sedation and other side effects. Patients are advised to avoid alcohol while on this medication.
Furthermore, these capsules may interact with other medications used to treat seizures, such as phenytoin, carbamazepine, and valproic acid. Monitoring for signs of increased seizure activity is crucial, and patients should inform their healthcare provider if they experience any changes in seizure frequency or severity.
If you have any questions about the potential interactions of Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules, please consult with your healthcare provider.
Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules are a compounded formulation of two potent medications, designed to treat a range of conditions. The Belladonna Extract acts as an anticholinergic agent, blocking the action of acetylcholine, a neurotransmitter in the body. This action helps to alleviate muscle spasms, reduce secretions, and manage pain. On the other hand, Phenobarbital is a barbiturate that functions by decelerating the activity of the brain and nervous system, thereby helping to mitigate anxiety, control seizures, and induce sleep.
When combined, these two active ingredients can effectively manage a variety of conditions, including anxiety, insomnia, muscle spasms, and seizures. The unique feature of this formulation is the incorporation of Methocel E4M, a controlled-release polymer. This ensures that the medication is gradually released over an extended period, providing a sustained therapeutic effect. This slow release mechanism not only enhances the efficacy of the medication but also reduces the dosing frequency, thereby improving patient compliance.
It is crucial to adhere to the prescribed dosage of Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules. Taking more or less than the recommended amount, or for a longer duration than advised, can lead to undesirable effects. It is also recommended to avoid alcohol and other medications that may interact with this formulation.
If you have any queries or concerns regarding Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules, do not hesitate to reach out for professional advice. Understanding how this medication works and how it can help manage your condition is key to achieving optimal therapeutic outcomes.
This compounded formulation of Belladonna Extract 20 mg/Phenobarbital 50 mg Slow Release Capsules, formulated with Methocel E4M, a type of controlled-release polymer, is designed to gradually release the encapsulated medication over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile. This formulation may be used to treat a variety of conditions including spasticity, muscle spasms, certain types of pain, and various types of seizures such as absence seizures, myoclonic seizures, and tonic-clonic seizures. It may also be beneficial for certain types of anxiety disorders, including panic disorder, social anxiety disorder, and generalized anxiety disorder. This formulation can also be used to manage certain types of insomnia, such as difficulty falling asleep, difficulty staying asleep, and early morning awakenings. Lastly, it may be used to treat certain types of migraines, such as migraines with aura and migraines without aura. If you have any questions about the use of this formulation for any of these conditions, please reach out for further information.
These capsules are designed to gradually release the encapsulated medication over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to control the release of the active ingredients over time.
Due to the slow-release nature of these capsules, the frequency of dosing is reduced. However, the exact frequency will depend on your doctor's prescription.
Slow-release formulations offer several benefits. They provide sustained therapeutic effects, reduce the need for frequent dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
A controlled and prolonged release profile means that the medication is designed to be released gradually over an extended period of time, rather than all at once. This helps to maintain a steady level of the medication in your body.
No, the capsules should not be opened or crushed. They are designed to release the medication slowly. If you open them, you may get too much of the medication at once.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time.
If you experience any side effects, contact your healthcare provider immediately. They can provide you with the necessary guidance and treatment options.
Before starting any new medication, it is important to discuss with your healthcare provider. They will be able to advise you on potential interactions and whether it is safe to take with other medications.
Store these capsules in a cool, dry place, away from direct sunlight. Keep them out of reach of children and pets. Do not use the capsules past their expiry date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
